IMAP India has advised Bilcare Research in multiple transactions involving M&A and corporate finance.
Bilcare is market leader in pharma packaging, packaging innovation and research that partners with the pharmaceutical industry to improve patient health-care outcomes. Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid). Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products. Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects. Bilcare Technologies provides track and trace, authentication and Anti-counterfeit (nCID – nonclonableID) solutions for product & people ID authentication and security.
IMAP India has been advising them for multiple transactions involving financial restructuring, M&A involving consolidation of its pharma packaging business with Caprihans, working capital raise and other advisory services.
“When it comes to the specific industry knowledge and the connectivity within which they are able to pull the resources and the knowledge bank I think it’s been very innovative. Skill set what I see in IMAP is so unique for a mid-sides corporate to really take them to the right path and more importantly give them the right advice”
Mohan Bhandari, Founder and CEO – Bilcare Research
Here is what the client has to say about IMAP, their journey with IMAP, understanding of IMAP team about their requirements and industry knowledge.
